| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/11/2002 | EP0934257B1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 12/11/2002 | EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 12/11/2002 | EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 12/11/2002 | EP0802985B1 Cell cycle regulated repressor and dna element |
| 12/11/2002 | EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 12/11/2002 | EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/11/2002 | EP0721455B1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 12/11/2002 | CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases |
| 12/11/2002 | CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives |
| 12/11/2002 | CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 12/11/2002 | CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 12/11/2002 | CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation |
| 12/11/2002 | CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist |
| 12/11/2002 | CN1384819A 前列腺素e类似物 E prostaglandin analogs |
| 12/11/2002 | CN1384817A Polymorphic N-[3-[[2-(3,4-dimethyoxyphenyl)ethyl]amino]propyl]-4-nitro benzamide hydrochloride |
| 12/11/2002 | CN1384756A Pharmaceutical formulations and use thereof in prevention of stroke, diabetes and/or congestive heart failure |
| 12/11/2002 | CN1384749A Use of diphophonic acid in treatment of vasculogenesis |
| 12/11/2002 | CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions |
| 12/11/2002 | CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors |
| 12/11/2002 | CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 12/11/2002 | CN1384740A Delayed-action form of administration containing tramadol saccharinate |
| 12/11/2002 | CN1384739A Oral pharmaceutical forms of administration with a delayed action |
| 12/11/2002 | CN1384735A Oral dosage forms |
| 12/11/2002 | CN1384733A Dry powder compositions having improved dispersivity |
| 12/11/2002 | CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative |
| 12/11/2002 | CN1384090A Extraction process of tanshin general phenolic acid and its prepn and use |
| 12/11/2002 | CN1383877A Prescription for treating piles |
| 12/11/2002 | CN1383871A Notoginseng and fermented red rice composition for preventing and treating cardiac and cerebral vascular diseases |
| 12/11/2002 | CN1383847A Chinese medicine composition for treating sequelae for cerebral infraction |
| 12/11/2002 | CN1383846A Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
| 12/11/2002 | CN1383841A Chinese medicine prepn for treating anorectal diseases |
| 12/11/2002 | CN1383837A Composite medicine for treating cardiac and cerebral vascular disease and its production process |
| 12/11/2002 | CN1383835A Gangrene treating ointment, vital energy-invigorating and blood circulation-promoting detoxication decoction, Yang-warming and blood circulation-promoting decoction |
| 12/11/2002 | CN1383825A Flunarizine hydrochloride injection and its prepn process |
| 12/11/2002 | CN1383823A Method of applying MEK inhibitor to treat or inhibit neutrophil chemotaxis |
| 12/11/2002 | CN1383817A Oral Breviscapine slow release prepn |
| 12/11/2002 | CN1095839C 4,5-diaryl oxazole derivatives |
| 12/11/2002 | CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative |
| 12/11/2002 | CN1095674C Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease |
| 12/11/2002 | CN1095669C Medicine composition for saponin containing protopanaxyndiol component and preparing process and application thereof |
| 12/11/2002 | CN1095663C Method for inhibiting LDL oxidation and atherosclerosis |
| 12/11/2002 | CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum |
| 12/11/2002 | CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 12/10/2002 | USRE37933 Locally administering to mammalian vascular smooth muscle cells replication defective recombinant adenovirus comprising gene encoding mammalian gax protein, wherein gene is expressed and proliferation of cells is inhibited |
| 12/10/2002 | US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis. |
| 12/10/2002 | US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems |
| 12/10/2002 | US6492425 Inhibitors of transcription factor-NF-κB |
| 12/10/2002 | US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 12/10/2002 | US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/10/2002 | US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer |
| 12/10/2002 | US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders |
| 12/10/2002 | US6492407 Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones |
| 12/10/2002 | US6492406 Pharmaceutically active compounds |
| 12/10/2002 | US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability |
| 12/10/2002 | US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage |
| 12/10/2002 | US6492396 Substituted thioacetamides |
| 12/10/2002 | US6492393 Compounds useful as anti-inflammatory agents |
| 12/10/2002 | US6492384 Imidazo (4,5-C) pyridine-4-one derivatives with factor XA inhibiting effect |
| 12/10/2002 | US6492382 Dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound |
| 12/10/2002 | US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 12/10/2002 | US6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 12/10/2002 | US6492374 Benzofuran derivatives, their preparation and use |
| 12/10/2002 | US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 12/10/2002 | US6492368 Benzamidine derivatives as factor XA inhibitors |
| 12/10/2002 | US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 12/10/2002 | US6492365 Microsomal triglyceride transfer protein |
| 12/10/2002 | US6492358 For treatment of sexual disorders, male erectile dysfunction |
| 12/10/2002 | US6492348 Adenosine derivatives |
| 12/10/2002 | US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 12/10/2002 | US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf |
| 12/10/2002 | US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 12/10/2002 | US6491915 Anti-CCR2 antibodies and methods of use therefor |
| 12/10/2002 | CA2244454C Use of nitric monoxide for preparing medication for intravascular administration |
| 12/10/2002 | CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient |
| 12/10/2002 | CA2208792C Substituted indazole derivatives |
| 12/10/2002 | CA2088574C Process for producing enzymes having superoxide dismutase activity, novel superoxide dismutase enzymes and novel pharmaceutical compositions comprising enzymes having superoxide dismutase activity |
| 12/09/2002 | WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 12/09/2002 | WO2001096366A2 Dipeptide inhibitors for the blood-clotting factor xa |
| 12/09/2002 | CA2412181A1 Dipeptide inhibitors for the blood-clotting factor xa |
| 12/09/2002 | CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments |
| 12/08/2002 | CA2817619A1 Methods of administering anti-tnf.alpha. antibodies |
| 12/08/2002 | CA2385745A1 Methods of administering anti-tnf.alpha. antibodies |
| 12/06/2002 | WO2002000605A1 Novel dicarboxylic acid derivatives |
| 12/06/2002 | CA2411059A1 Novel dicarboxylic acid derivatives |
| 12/05/2002 | WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 12/05/2002 | WO2002097116A2 Delivery system for nucleic acids |
| 12/05/2002 | WO2002097060A2 Carbohydrate-associated proteins |
| 12/05/2002 | WO2002097053A2 Small molecule antagonists of bcl2 family proteins |
| 12/05/2002 | WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 12/05/2002 | WO2002097035A2 Secreted proteins |
| 12/05/2002 | WO2002097032A2 Proteins associated with cell growth, differentiation, and death |
| 12/05/2002 | WO2002097030A2 Peptides derived from neural thread proteins and their medical use |
| 12/05/2002 | WO2002096937A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 12/05/2002 | WO2002096932A1 Transporters and ion channels |
| 12/05/2002 | WO2002096927A2 Ribozyme based treatment of female reproductive diseases |
| 12/05/2002 | WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 12/05/2002 | WO2002096904A1 Novel heterocyclic derivatives and medicinal use thereof |
| 12/05/2002 | WO2002096896A1 Biologically active methylene blue derivatives |
| 12/05/2002 | WO2002096895A1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| 12/05/2002 | WO2002096894A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases |